반응 #2045061

ord-d4cab34bc824435d9fa5102119506a3f

반응 방정식

CCC(CC)COC(C(=O)N(C)CC[NH+](C)C)(c1ccccc1)c1ccccc1.[Cl-]
X-100
CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O
leupeptin
CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C
pepstatin
Cl.NC(CO)(CO)CO
Tris-HCl
O=P([O-])([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]
sodium pyrophosphate
O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
EDTA
O[C@H](CS)[C@H](O)CS
DTT
O=S(=O)(F)Cc1ccccc1
phenylmethylsulfonyl fluoride
OCC(O)CO
glycerol
O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Glucose

반응 조건

온도
-80°CELSIUS
상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타Fresh intact proximal jejunum was removed
  2. 2
    세척washed with saline
  3. 3
    기타were removed
  4. 4
    workup.ADDITIONcontaining 50 mM mannitol and protease inhibitors (5 μM aprotinin, leupeptin, and pepstatin)
  5. 5
    workup.ADDITIONPEG 4000 was added to a final concentration of 10%
  6. 6
    workup.STIRRINGstirred on ice for 15 minutes
  7. 7
    workup.WAITg for 60 minutes at 4° C
  8. 8
    세척The pellet was washed in suspension buffer (10 mM Tris-HCl, pH 7.1
  9. 9
    workup.ADDITIONcontaining 300 mM mannitol and protease inhibitors 5 μM aprotinin
  10. 10
    기타leupeptin, and pepstatin) and collected again by centrifugation for 5 minutes
  11. 11
    기타g at 4° C
  12. 12
    기타For preparation of total membranes
  13. 13
    온도frozen jejunum sections (1 g)
  14. 14
    workup.WAITg for 20 minutes at 4° C.
  15. 15
    기타to remove insoluble material

실험 절차

Fresh intact proximal jejunum was removed, washed with saline and placed on ice while approximately 4 g of mucosa were removed and transferred to cold 2 mM Tris-HCl buffer (pH 7.1) containing 50 mM mannitol and protease inhibitors (5 μM aprotinin, leupeptin, and pepstatin). The mucosa was then homogenized and PEG 4000 was added to a final concentration of 10% and stirred on ice for 15 minutes. The homogenate was then centrifuged for 15 minutes at 7,500×g and the resulting supernatant fraction centrifuged at 27,000×g for 60 minutes at 4° C. The pellet was washed in suspension buffer (10 mM Tris-HCl, pH 7.1, containing 300 mM mannitol and protease inhibitors 5 μM aprotinin, leupeptin, and pepstatin) and collected again by centrifugation for 5 minutes, 27,000×g at 4° C. The crude brush border membrane (BBM) pellet was suspended in 1 mL of suspension buffer. For preparation of total membranes, frozen jejunum sections (1 g) were and homogenized on ice in 700 μL Buffer A (50 mM Tris-HCl pH 7.5, 50 mM NaF, 5 mM sodium pyrophosphate, 1 mM EDTA, 1 mM DTT, 0.1 mM phenylmethylsulfonyl fluoride, 10% glycerol) containing 1% Triton X-100 and 5 μM aprotinin, leupeptin, and pepstatin. The homogenates were centrifuged at 6,000×g for 20 minutes at 4° C. to remove insoluble material. The protein concentrations of the total and BBM preparations were determined using BCA reagents (Pierce, Rockford, Ill. USA). Final total and brush border membrane preparations were frozen at −80° C. until assayed. The purity of the brush border membrane preparations as measured by alkaline phosphatase were not affected by treatment (data not shown).

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08409585B2uspto-grants-2013_04